Cardiome Pharma

Cardiome Pharma (CRME), a biopharmaceutical company, engages in the discovery, development and commercialization of therapies that enhance the health of patients. This stock closed up 6.3% to $6.49 in Tuesday's trading session.

Tuesday's Range: $6.08-$6.55
52-Week Range: $1.60-$7.15
Tuesday's Volume: 110,000
Three-Month Average Volume: 156,727

From a technical perspective, CRME spiked higher here right off some near-term support at $6 with lighter-than-average volume. This stock recently formed a double bottom chart pattern at $5.85 to $6. Since forming that bottom, shares of CRME have now started to spike higher and move within range of triggering a major breakout trade. That trade will hit if CRME manages to take out some key near-term overhead resistance levels at $6.95 to its 52-week high at $7.15 with high volume.

Traders should now look for long-biased trades in CRME as long as it's trending above $6 or above $5.85 and then once it sustains a move or close above those breakout levels with volume that hits near or above 156,727 shares. If that breakout hits soon, then CRME will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $9 to $10.

If you liked this article you might like

Dov Charney Wants You to Know That 'Made in America' Is Not Nationalist

American Apparel Files for Second Bankruptcy

11 Companies That Announced Big Job Cuts During Earnings

Stocks Climb in Year's Longest Winning Streak

S&P 500 on Track for Longest Winning Streak of 2015